Clinical Trial Update: Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating post-mastectomy hypofractionated radiotherapy for high-risk breast cancer; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ahmed Ahm | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN